Detalhe da pesquisa
1.
The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.
Blood
; 122(22): 3628-31, 2013 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24081659
2.
JAK2(V617I) results in cytokine hypersensitivity without causing an overt myeloproliferative disorder in a mouse transduction-transplantation model.
Exp Hematol
; 44(1): 24-9.e1, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26458983